Entity Common Stock, Shares Outstanding of Clearside Biomedical, Inc. from 05 Aug 2016 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Clearside Biomedical, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 05 Aug 2016 to 12 Nov 2025.
  • Clearside Biomedical, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 5,233,981, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Clearside Biomedical, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 5,233,981 -70,609,523 -93% 12 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 78,510,318 +3,764,746 +5% 08 Aug 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 77,143,872 +2,422,733 +3.2% 24 Mar 2025 10-K 27 Mar 2025 2024 FY
Q3 2024 75,843,504 +13,434,638 +22% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 74,745,572 +12,715,078 +20% 09 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 74,721,139 +13,356,840 +22% 05 Mar 2024 10-K 12 Mar 2024 2023 FY
Q3 2023 62,408,866 +2,218,135 +3.7% 08 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 62,030,494 +1,839,763 +3.1% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 61,364,299 +1,216,681 +2% 08 Mar 2023 10-K 14 Mar 2023 2022 FY
Q3 2022 60,190,731 +524,212 +0.88% 07 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 60,190,731 +711,163 +1.2% 10 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 60,147,618 +2,725,143 +4.7% 07 Mar 2022 10-K 11 Mar 2022 2021 FY
Q3 2021 59,666,519 +11,312,567 +23% 05 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 59,479,568 +13,137,349 +28% 06 Aug 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 57,422,475 +12,553,917 +28% 10 Mar 2021 10-K 15 Mar 2021 2020 FY
Q3 2020 48,353,952 +7,204,171 +18% 06 Nov 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 46,342,219 +8,582,438 +23% 07 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 44,868,558 +8,829,313 +24% 11 Mar 2020 10-K 13 Mar 2020 2019 FY
Q3 2019 41,149,781 +9,125,558 +28% 04 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 37,759,781 +5,735,558 +18% 05 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 36,039,245 +4,126,132 +13% 11 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 32,024,223 +6,681,778 +26% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 32,024,223 +6,687,741 +26% 06 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 31,913,113 +6,627,097 +26% 12 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 25,342,445 +4,774,265 +23% 09 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 25,336,482 +4,790,966 +23% 04 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 25,286,016 10 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 20,568,180 10 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 20,545,516 05 Aug 2016 10-Q 12 Aug 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.